Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.33 |
| ▸ | LTA4H | P09960 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16726511 | 1.00 | TSHR (0.33) | TSHRCHRNB4CHRNA3ALDH1A1L3MBTL1 | |
| SCHEMBL10222509 | 0.74 | SMN1; SMN2 (0.50) | CHRNB4CHRNA3ALDH1A1L3MBTL1CHRNB2 | |
| SCHEMBL7144522 | 0.73 | P2RX4 (0.32) | P2RX4 | |
| SCHEMBL20027221 | 0.72 | GPR3 (0.39) | TSHRCHRNB4CHRNA3ALDH1A1L3MBTL1 | |
| SCHEMBL16728888 | 0.72 | GPR3 (0.39) | TSHRCHRNB4CHRNA3ALDH1A1L3MBTL1 | |
| SCHEMBL23031962 | 0.72 | CHRNB4 (0.43) | CHRNB4CHRNA3CHRNB2CHRNA4 | |
| SCHEMBL21013944 | 0.72 | CHRM1 (0.31) | — | |
| SCHEMBL14822283 | 0.72 | GAA (0.35) | ALDH1A1 | |
| SCHEMBL21901747 | 0.71 | P2RX4 (0.34) | TSHRCHRNB4CHRNA3ALDH1A1L3MBTL1 | |
| SCHEMBL16709153 | 0.69 | TSHR (0.36) | TSHRCHRNB4CHRNA3ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10033000-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-07-24 | — | — | US | disclosed |
| US-20150137096-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10033000-B2 | Organic electroluminescent materials and devices | LSM8, OPRM1, OXER1 | TSHR 2879/4885CHRNB4 1395/4885CHRNA3 693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.